Parnassus Investments, an investment management firm that focuses on owning a concentrated portfolio of U.S. large cap stocks ...

In the cutthroat pharmaceutical arena, Pfizer stands poised for a strategic pivot and a potential earnings bonanza in 2025.

A $150 million redevelopment plan will convert the former Pfizer campus in Peapack-Gladstone into a senior living community.

Wall Street expects a year-over-year decline in earnings on higher revenues when Pfizer (PFE) reports results for the quarter ...

Scientists in Turkey found that the Pfizer COVID-19 vaccine impacted some people's corneas, according to a study.

Pfizer's $43B Seagen deal strengthens its oncology portfolio, offsets patent cliffs, and offers 70%+ upside potential. See ...

Pfizer has lagged behind the broader market over the past year, but analysts maintain a cautiously optimistic outlook on the ...

The move is expected to cause a “near-term stock out of Bicillin L-A,” Pfizer said in its statement, with the drugmaker now ...

BioNTech SE and Pfizer (PFE) recently received a positive recommendation from the European Medicines Agency for marketing ...

I can’t ask you to do that because we are still on the verge of finding out what the Seagen acquisition does. Let’s give Dr.

A team of researchers in Turkey have discovered multiple signs of stress in the eye after patients took Pfizer's COVID-19 ...

Pfizer's innovations include vaccines, medicines, energy, and biodiversity projects, driven by their ESG Strategy and sustainability initiatives.